Monday, March 24, 2008

Lucid’s VivaScope® Reflective Confocal Microscope Approved for Sale in China

ROCHESTER, NY, USA, - March 24, 2008 – China’s State Food and Drug Administration has approved the sale of the pioneering Lucid VivaScope® reflective confocal microscope in the Peoples Republic of China, said Jay Eastman, CEO of Lucid, a Rochester, New York-based medical device and information company dedicated to providing improved care for dermatology patients.

Lucid’s VivaScope® reflective confocal microscopes (RCM) provide non-invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions -- without the need for surgery to excise tissue – thus improving the quality of care for their patients.

“Just as MRI and CT scans have largely eliminated the need for routine ‘exploratory surgery’, the use of Lucid’s VivaScope® confocal microscopes may one day eliminate the need for routine invasive skin biopsies,” Eastman explained.

“This milestone announcement opens opportunities for application of confocal microscopes to evaluate and monitor treatment of skin inflammatory and pigmentation disorders with leading hospitals throughout China,” Eastman said.

“I am very pleased to see this positive outcome from a long and detailed review process that will allow us to participate in one of the fastest growing medical markets in the world,” he said. “We believe that reflectance confocal microscopes will become a standard clinical tool with its capacity to take painless, non-invasive optical biopsies of a wide range of skin lesions and disorders.”

Sales of Lucid’s VivaScope® confocal microscopes in China will be handled by ConBio (China) Co., Ltd, Eastman said.

Dr Qiushi Ren, CEO, ConBio said, “We are excited by the opportunity to introduce Lucid’s unique, leading RCM technology to Chinese doctors and building our business together.”

Founded in 1996, ConBio is a multi-specialty health care company focused on providing innovative medical devices that enable people to live life to its greatest potential. ConBio has built strategic relationships with famous manufacturers in the dermatology, plastic and ophthalmologic fields around the world, including Lucid, Cutera, RA Medical, MedArt, Lutronic, Allergan, Schwind with a goal of becoming the leading provider of the advanced medical lasers, instruments and materials in China. ConBio has successfully sold more than 1,000 units of capital equipment to customers in China and prides itself on their after-sales service.

For information, visit Lucid’s website at http://www.lucid-tech.com. Contact Lucid in China at ConBio (China) Co., Ltd., by email at qren@shanghai-conbio.com or by phone at: + 86 21 62720751. In the USA, contact Lucid by email at info@lucid-tech.com, or by phone at +1-585-239-9800.

About Lucid, Inc.
Lucid, Inc. (www.lucid-tech.com), based in Rochester, New York (USA) is a medical device and information company with offices in North America, Europe, and Australia. Lucid is dedicated to providing improved care for dermatology patients by coupling its noninvasive VivaScope® cellular imaging technology with its innovative VivaNet® medical information system to allow secure, HIPAA compliant, near real-time collaboration between dermatologists and other medical specialists. The VivaNet® system provides rapid online medical image transfer, storage, and retrieval thus enabling these critical collaborative consultations. The technologies delivered by Lucid provide images that physicians use in forming critical clinical judgments in cases of dermatologic disease, while ensuring patient comfort and piece of mind.

VivaNet® and VivaScope® are registered trademarks of Lucid, Inc.


# # #

Labels: , , , , , , , , , , , ,

Monday, February 25, 2008

International Confocal Microscopy Working Group Established to Advance Practice of Reflective Confocal Microscopy

Ft. Lauderdale, FL, USA – February 25, 2008 – The International Confocal Microscopy Working Group, an independent group of medical professionals and students, has been formed as a means to promote the betterment and increased use of reflective confocal microscopy (RCM) in patient care.

The Working Group is open and welcoming new members worldwide. Dermatologists, dermascopists, dermatopathologists, medical students and other professionals interested in learning more about RCM should consider joining the working group. RCM is a new medical imaging technology that noninvasively provides cellular resolution images of the skin. These images can assist physicians in identification of skin disease and monitoring treatment.

At the first meeting, which was held at the American Academy of Dermatology (AAD) 66th Annual Meeting in San Antonio earlier this month, the Working Group established organization and membership guidelines, opportunities for collaborative research, and opportunities for training and recent scientific research in RCM.

The International Confocal Microscopy Working Group’s mission is to create an international collaborative consortium that educates, encourages and promotes research by the medical community on the discipline and practice of RCM.

Created by leading dermatologists with international affiliations, the International Confocal Microscopy Working Group intends to lay the groundwork to create broad acceptance of RCM for the diagnosis of skin cancers and conditions.

The Working Group founders include Dr. Salvador González of Memorial Sloan Kettering Cancer Center (New York) and Ramon y Cajal Hospital (Madrid); Dr. Giovanni Pellacani of University of Modena and Reggio Emilia; Dr. Josep Malvehy of Hospital Clinic Barcelona and CEDILP; and Dr. Susana Puig of Hospital Clinic Barcelona and CEDILP.

For more information about the Working Group, including membership information, contact Maggie Oliverio by email at Maggie@ADMCORP.com and reference in the subject line “International Confocal Microscopy Working Group.”

About The International Confocal Microscopy Working Group
The International Confocal Microscopy Working Group is an independent group of medical professionals and students interested in the betterment and increased use of confocal microscopy in patient care. The Group welcomes new members. For information regarding membership, please contact Maggie Oliverio, Maggie@ADMCORP.com and reference in the subject line “International Confocal Microscopy Working Group.”

# # #

Labels: , , , , , , ,

Wednesday, February 20, 2008

First Atlas Detailing In Vivo Reflectance Confocal Microscopy Published

ROCHESTER, NEW YORK, USA – February 20, 2008 – As skin cancer cases continue to rise, the worldwide deployment of In Vivo Reflectance Confocal Microscopy (RCM) (Confocal Imaging) technology – which produces digital images of a patient’s skin with cellular detail similar to that obtained from histology of surgical biopsies – can help healthcare practitioners both speed and improve their clinical judgments and assist in monitoring treatment. In support of RCM technology, the world’s first available comprehensive atlas detailing the technology has been published.

"Reflectance Confocal Microscopy of Cutaneous Tumors: An Atlas with Clinical, Dermoscopic and Histological Correlations" (Salvador González, Melissa Gill, and Allan C. Halpern, Editors; Informa Healthcare, Publisher), is a comprehensive, full-color atlas detailing the potential of RCM technology and its possible applications for clinical practitioners. The hard-cover first edition atlas totals 280-pages.

Specifically, In Vivo Reflectance Confocal Microscopy allows optical sectioning of an area of skin without physical sectioning, assisting dermatologists to examine detailed features of a skin lesion without taking a biopsy specimen. RCM technology can also assist dermatopathologists to determine the best location for a section and dermatological surgeons to determine the margins of a lesion to be excised.

The contents of "Reflectance Confocal Microscopy of Cutaneous Tumors" are:
I. BASIC PRINCIPLES
II. NORMAL SKIN
III. KERATINOCYTIC TUMORS (Seborrheic keratoses, Clear cell acanthoma, Porokeratosis, Squamous neoplasia, Basal cell carcinoma)
IV. MELANOCYTIC TUMORS (Lentigo, Congenital and common acquired melanocytic nevi, Dysplastic nevi, Malignant melanoma, Blue nevus, Spitz nevus)
V. OTHER TUMORS (Trichoepithelioma, Sebaceous hyperplasia, Dermatofibroma, Angioma, Mycosis fungoides)
VI. CLINICAL APPLICATIONS (Adjunct to clinical diagnosis, RCM-guided biopsy site selection, RCM-assisted assessment of treatment response, RCM-assisted in-vivo margin mapping, RCM-Assisted ex-vivo margin assessment)
VII. FUTURE PERSPECTIVES

The editors of the atlas are three of the world’s leading RCM medical researchers: Salvador González, M.D., Ph.D., Faculty, Dermatology, MSKCC, New York, NY, Assistant Prof, Dermatology, HMS, Boston, Mass., USA; Melissa Gill, M.D., Dermatopathologist, Quest Diagnostics Inc., Teterboro, New Jersey, USA (formerly with MSKCC, New York, NY); and Allan C. Halpern, Chief, Dermatology Service, Memorial Sloan-Kettering Cancer Center, New York, NY USA.

"Reflectance Confocal Microscopy of Cutaneous Tumors" (ISBN: 9780415451048) is available immediately from Informa Healthcare (http://catalogue.informahealthcare.com/) at http://catalogue.informahealthcare.com/pjbp/products/10001043243;jsessionid=2F12CE3F716298BA32B2362B147D00B6.

Lucid Inc. an RCM Leader
The leader in the development and worldwide deployment of RCM technology is Lucid, Inc. (http://www.lucid-tech.com/) of Rochester, New York, USA. Lucid is the creator of the VivaScope® reflective confocal microscopy imaging microscope and of the VivaNet®, a network-based, DICOM-compliant medical information system that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images.

Atlas author Dr. González is among several European diagnostic readers providing confocal imaging services for European dermatology patients using Lucid’s VivaScope® Confocal Imagers. The readers are also beginning validation testing of Lucid’s VivaNet® telemedicine information system of transferring and managing clinical data between the private practitioners and the diagnostic readers.

For information on Lucid’s VivaScope® or VivaNet® technology, contact Lucid on the web at http://www.lucid-tech.com/, by email at info@lucid-tech.com, or by phone at +1-585-239-9800.

# # #

Labels: , , , , , , , , , , , ,

Tuesday, February 12, 2008

Lucid Launches VivaNet® Telemedicine Server for Dermatology Applications

ROCHESTER, NY, USA, - February 12, 2008 – Lucid, Inc. (http://www.lucid-tech.com/) today announced the launch of its secure VivaNet® telemedicine server and network. The network is designed to transfer and manage clinical data between dermatology practitioners using Lucid’s non-invasive VivaScope® Confocal Imagers with pathologists or other medical specialists.

Lucid’s VivaScope® confocal imager microscopes provide non-invasive, in-vivo cellular resolution images of skin. Dermatologists can use the images to form a clinical judgment for a variety of skin conditions -- without the need to excise tissue.

The VivaNet® network provides fast, accurate and secure storage, retrieval, and transfer of VivaScope images across the Internet or Lucid’s private network service. Its launch will make VivaScope® images available for review by other dermatologists and pathologists in minutes – thus enabling rapid, real-time professional collaboration.

“With VivaNet®, practitioners can rapidly receive a pathologic interpretation of confocal images from a VivaScope® session, potentially assisting physicians in arriving at a clinical judgment while a patient is still in the doctor’s office,” said Jay Eastman, CEO, Lucid Inc.

“Just as MRI and CT scans have largely eliminated the need for routine ‘exploratory surgery’, the use of the VivaNet® network in conjunction with VivaScope® confocal microscopes may one day eliminate the need for routine invasive skin biopsies,” he said.

During a typical session, once VivaScope® images are captured, they are uploaded to the secure VivaNet® server, along with other patient-related data. From there, the patient image set is immediately available for retrieval by and transfer to other authorized practitioners.

The advantages of the VivaNet® network include:
  • Secure sharing of digital cellular resolution images among medical professionals
  • Fast, accurate, secure information exchange to enable clinical judgments of patient skin lesions
  • Rapid, near-real-time clinical reporting
  • Ensured HIPAA compliance, privacy, and data integrity via DICOM-compliant, standardized medical image storage, retrieval, and transfer

The VivaNet® network has been launched for near term use by dermatologists, as users of the VivaScope® microscopes, and pathologists, as readers of VivaScope images, in the US, Europe and Australia. For more information, visit http://www.lucid-tech.com/ or call +1-585-239-9800.

About Lucid, Inc.
Lucid, Inc. (http://www.lucid-tech.com/), based in Rochester, New York (USA) is a medical device and information company with offices in North America, Europe, and Australia. Lucid is dedicated to providing improved care for dermatology patients by coupling its noninvasive VivaScope® cellular imaging technology with its innovative VivaNet® medical information system to allow secure, HIPAA compliant, near real-time collaboration between dermatologists and other medical specialists. The VivaNet® system provides rapid online medical image transfer, storage, and retrieval thus enabling these critical collaborative consultations. The technologies delivered by Lucid provide images that physicians use in forming critical clinical judgments in cases of dermatologic disease, while ensuring patient comfort and piece of mind.

VivaNet® and VivaScope® are registered trademarks of Lucid, Inc.

# # #

Labels: , , , , , , , , , , , ,

Tuesday, December 11, 2007

Lucid Expands Support Internationally: Dr. Colin Stahel appointed Director for Asia Pacific Region

ROCHESTER, NEW YORK, USA – December 11, 2007- Lucid, Inc. (http://www.lucid-tech.com/), a leading U.S. cellular imaging and technology company, has appointed Dr. Colin Stahel as Director, Asia Pacific Region.

Based in Sydney, Australia, Stahel was selected for the newly created position based on his extensive medical technology experience.

“With over twenty years of experience in the development of medical technology and pre-cancer and cancer detection equipment, Stahel is a welcome addition to the Lucid team,” said Jay Eastman, chairman and CEO of Lucid, Inc (http://www.lucid-tech.com/). “His knowledge of the field will suit his new responsibilities in the international community.”

Previously, Stahel was the senior manager with Polartechnics where he worked directly with the SolarScan digital dermatoscope and TruScreen Division for real time detection of cervical cancer, both based in Australia.

Dr. Colin D. Stahel holds a Ph.D. in physiology from the Faculty of Medicine, University of Tasmania in Australia, and a MBA from Macquarie University of Australia.

Lucid is the creator of the non-invasive VivaScope confocal microscope that provided cellular resolution images of skin, and of the VivaNet, an internet-based, DICOM-compliant medical information systems that enables the transfer of VivaScope digital images between practitioners and pathologists for rapid review of confocal images. Lucid’s VivaScopes are in regular use throughout the United States, Europe, and Australia.

For more information about Lucid Inc., visit http://www.lucid-tech.com/ or call 1-585-239-9800.

About Lucid, Inc.
Lucid Inc., based in Rochester, New York, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. The Company’s digital VivaNetTM server, coupled with its ability to image in-vivo (living) tissue is envisioned to ultimately aid medical practitioners and pathologists in screening for skin cancer and other dermatologic conditions with clarity, speed and patient comfort. For more information, visit http://www.lucid-tech.com/.

# # #

Labels: , , , , , , , , , , , ,

Wednesday, December 05, 2007

William Shea Elected as Chairman of Lucid, Inc.

ROCHESTER, NEW YORK, USA – December 5, 2007 – William J. Shea has been elected to serve as Chairman of Lucid, Inc., the leading medical cellular imaging technology and information company. Shea brings a wealth of executive and financial leadership to the company, having previously served as CEO of Conseco, Vice Chairman and CFO of BankBoston and senior partner and Vice Chairman of Coopers and Lybrand (now PricewaterhouseCoopers).

As Lucid Board Chairman, Shea will be responsible for managing the Board's business in its fiduciary role for shareholders and in its supervisory and advisory roles to the CEO and the management team of the company.

“Lucid is well positioned to transition its VivaNet technology from clinical research to routine clinical application and the company’s compelling business model is well protected by patents, both in the United States and abroad,” Shea stated. “I am looking forward to assisting the company through the exciting and challenging growth stage we envision in the next few years ahead.”

Shea, a resident of Andover, Mass., is a veteran corporate leader with a series of dramatic success stories within the financial services industry. He previously held the position of CEO of Conseco, an insurance, annuity, and financial services company. In the position, Shea increased the company’s market capitalization by more than $3.5 billion.

Before that, Shea was Vice Chairman and CFO of BankBoston where he led a fundamental restructuring that increased shareholder value tenfold.

“I am delighted that Bill Shea accepted the position of Chairman of Lucid’s Board of Directors,” said Jay Eastman, CEO of Lucid. “Bill’s experience will be invaluable resource to me and the other members of the company’s management team as we commercialize our VivaNet technology in the United States, Europe and Australia.”

Lucid (www.lucid-tech.com) is an innovative and dynamic company with a broad technology portfolio in the medical imaging and information fields. Based in Rochester, New York, the company is creator of the non-invasive VivaScope® confocal microscope that provides cellular resolution images of skin, and of the VivaNet™, an Internet-based, DICOM-compliant medical information system that enables the transfer of confocal images between practitioners and pathologists for rapid review and diagnosis.

For more information, visit Lucid online at www.lucid-tech.com, by email: info@lucid-tech.com, or by phone: 585-239-9800.

# # #

Labels: , , , , , , , , , , , ,

Monday, November 19, 2007

Lucid Expands Support, Development for Cellular Imaging Technology Network

ROCHESTER, NEW YORK, USA – November 19, 2007 – Lucid, Inc. (http://www.lucid-tech.com/), a leading U.S. cellular imaging and technology company, today announced the appointment of Kenneth Centola of Hilton, New York as Imaging Specialist and Christian Costa of Macedon, New York as Applications Engineer.

“Customer service is the cornerstone of Lucid’s sales and marketing policy. With the addition of Ken and Christian to the Lucid team, we are further raising the bar on our service offering,” said John Nugent, vice president of global sales and marketing for Lucid.

In the newly created position, Centola will work directly with Lucid’s VivaNet imaging sites worldwide. He will help in the creation of community based sites, train onsite imagers, and monitor ongoing performance. Centola holds a degree in Radiologic Technology from Monroe Community College in Rochester, New York, and is a licensed Radiologic Technologist by the New York State Department of Health.

Costa will work in business development for Lucid and act as a liaison with medical professionals and customers with relation to the demonstration, installation, and training of VivaScope products. Costa will also consult with engineering personnel to track customer satisfaction, product performance, and product improvements.

Lucid is the creator of the non-invasive VivaScope® confocal microscope that provides cellular resolution images of skin, and of the VivaNet™, an Internet-based, DICOM-compliant medical information system that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images.

For more information about Lucid and Confocal Imaging solutions, visit http://www.lucid-tech.com/ on the Web, by phone at 1-585-239-9800, or by email info@lucid-tech.com.

About Lucid Inc.
Lucid, Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to deploying its innovative cellular imaging technology and using the VivaNet Internet based medical information system to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. When coupled with its digital VivaNetTM system, the company’s ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit http://www.lucid-tech.com/ or call +1-585-239-9800.

# # #

Labels: , , , , , , , , , , , ,

Thursday, October 18, 2007

Leading Dermatologists, Pathologists to Assemble for In-Depth Training Course on Confocal Diagnostic Image Interpretation

ROCHESTER, NEW YORK – October 18, 2007 – Lucid, Inc. (www.lucid-tech.com) today announced that leading dermatologists and pathologists from around the world will be assembling in Modena, Italy for the 2nd Confocal Diagnostic Readers’ Two-Day Training Course. This will be the second in a series of international courses designed to educate diagnostic readers on the interpretation of in-vivo confocal images.

Instructors for the two-day training course will be Dr. Giovanni Pellacani from the University of Modena and Reggio Emilia in Modena, Italy; Dr. Salvador González (Ramon y Cajal Madrid); Dr. Josep Malvehy (Hospital Clinic. Barcelona and CEDILP) and Dr. Susana Puig (Hospital Clinic. Barcelona and CEDILP). The event, to be sponsored in part by Lucid, developer of the VivaScope® confocal imagers and the VivaNet™ telemedicine information system, will be held at the University of Modena and Reggio Emilia, Italy, October 20- 21, 2007.

This training session will be held to support the 2008 commercial availability of Lucid’s VivaNet® telemedicine system throughout Europe.

“Lucid is delighted to provide the opportunity to educate confocal diagnostic readers. This educational process is a critical step if the dermatology community is to adopt in-vivo confocal imaging for widespread use in skin cancer screening,” said Jay M. Eastman, Chief Executive Officer of Lucid, Inc. He continued, “Due to the overwhelming demand, Lucid will offer a significantly expanded course schedule for imaging and diagnostic readers during 2008.”

Lucid’s non-invasive VivaScope® confocal microscopes provide cellular resolution images of skin that may be used by a physician to assist in forming a clinical judgment for a variety of skin conditions. Lucid’s VivaNet™, a HIPAA compliant DICOM-Network, is intended to provide fast, accurate, and secure storage, retrieval and transfer of VivaScope® digital cellular resolution images across the Internet to facilitate professional collaboration and consultation between the attending physician and confocal diagnostic readers.

For information on Lucid’s continuing series of courses and educational sessions, VivaScope® or VivaNetTM technology, contact Lucid by phone at 585-239-9800, by email at info@lucid-tech.com, or on the web at http://www.lucid-tech.com/.

About Lucid, Inc.
Lucid, Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to deploying its innovative cellular imaging technology and using the VivaNet Internet based medical information system to securely deliver accurate, real-time VivaScope cellular resolution images to medical professionals. When coupled with its digital VivaNet system, the company’s ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit http://www.lucid-tech.com/ or call +1-585-239-9800.

# # #

Public Relations contact: Tiziani Whitmyre Inc., http://www.tizinc.com/

post to del.icio.us

Technorati tags: , , , , , , , , , , , , , , , , ,

Labels: , , , , , , , , , , ,

Tuesday, October 16, 2007

VivaScope® Confocal Imager May Eliminate Need for Routine Skin Biopsies for Dermatology Patients

ROCHESTER, NY – October 16, 2007 -- Many routine surgical biopsies could become a thing of the past as dermatologists may soon be sharing, reviewing and diagnosing noninvasive digital images of skin cells via the Internet, using Lucid Inc.’s VivaNet™ telemedicine server and its VivaScope® confocal imagers.

The technology, which relies on using special microscopes to digitally image a patient’s skin, may bypass the need to surgically biopsy many patients. “VivaScope imaging sessions require only 5 to 10 minutes of a physician’s assistant’s time,” said Jay Eastman, Ph.D., CEO, Lucid Inc. (http://www.lucid-tech.com/.

The cellular resolution images may then be used by physicians to assist in forming a clinical judgment for a variety of skin conditions, including, for example, melanoma, basal cell carcinoma, actinic keratoses, and contact dermatitis.

A typical VivaScope imaging session produces two types of images of the patient’s skin: dermatoscopic-quality, full-color macroscopic pictures, and microscopic, cellular resolution images. Like a routine biopsy, the images can then be read by a dermatologist or a pathologist and the diagnosis presented to the patient.

“Just as MRI and CT scans have largely eliminated the need for routine exploratory surgery, in-vivo confocal imaging may one day eliminate the need for routine invasive skin biopsy,” Eastman stated.

Improving Quality of Life for Dermatology Patients

Already, dozens of Lucid’s VivaScopes are in regular use throughout the U.S. and Europe. “Lucid’s VivaScope® 1500 has the capability of imaging virtually all types of skin cancers, which makes it useful for many everyday procedures in a dermatology practice,” stated Dr. Harold Rabinovitz, a Florida based dermatologist who specializes in skin cancer. “The VivaScope is an incredible diagnostic tool and now routinely aids me in the clinical evaluation of potential skin cancers.”

The Company is also developing an Internet-based application, the Lucid VivaNetTM, to enable the transfer of VivaScope digital images between practitioners and pathologists for rapid review of confocal images. The VivaNet technology conforms to DICOM (Digital Imaging and Communications in Medicine), an internationally accepted standard for the secure storage, retrieval and transfer of medical images, and it complies with federal HIPAA requirements for privacy and integrity of medical data.

Ultimately, the VivaNet could make VivaScope images available for review by other dermatologists and pathologists – anywhere in the world – in minutes, not days – thus enabling rapid, real-time professional collaboration. The ultimate goal is that practitioners will rapidly receive a pathologic interpretation of confocal images from a VivaScope session, potentially assisting the practitioner in arriving at a clinical judgment while the patient is still in the doctor’s office, Eastman said.

“It’s our hope that the VivaScope and VivaNet will improve the quality of life for dermatology patients by eliminating the need for painful, invasive skin biopsies and drastically reducing the time required for diagnosis and treatment,” Eastman said.

For information on Lucid’s VivaScope or VivaNet technology, contact Lucid by phone at 585-239-9800, by email at info@lucid-tech.com, or on the web at http://www.lucid-tech.com/.

# # #

Public Relations contact: Tiziani Whitmyre Inc.

post to del.icio.us

Technorati tags: , , , , , , , , , , , , , , , , ,

Labels: , , , , , , , , , , , ,

Thursday, September 27, 2007

Lucid to Showcase VivaScope® In-vivo Confocal Imagers, VivaNet Telemedicine Server for Dermatology Applications at the World Congress of Dermatology

ROCHESTER, NEW YORK, USA – September 27, 2007 – Lucid, Inc. (http://www.lucid-tech.com/) will showcase their VivaScope® in-vivo confocal imagers and accompanying VivaNet™ telemedicine server at the 21st annual World Congress of Dermatology show, October 1-5, 2007.

Lucid’s non-invasive VivaScope confocal imagers and VivaNet telemedicine server are changing the day-to-day routine of dermatology practitioners at sites throughout Europe and the United States by enabling them to quickly and accurately identify a variety of skin conditions.

Visit Lucid, in booth #35 at the World Congress of Dermatology show, to learn more about the line of VivaScope advanced laser technology products that aid in the early detection of skin cancer and diseases. Lucid’s accompanying VivaNet is an Internet based medical image server that enables in-vivo, confocal images to be available for review by dermatologists and pathologists in minutes.

“The availability of Lucid’s VivaNet™ system should enable the routine use of confocal imaging in dermatology practices,” said Jay Eastman, CEO of Lucid, Inc. “Just as MRI and CT scans have largely eliminated the need for routine ‘exploratory surgery’, in-vivo confocal imaging may one day eliminate the need for many routine invasive skin biopsies,” Eastman said.

During a typical VivaScope imaging session, both dermatoscopic quality, full color macroscopic pictures and microscopic, cellular resolution images of the patient’s skin are imaged. Once all of the images for a single session are completed, the images and patient related data are transferred for storage to the secure VivaNet server and are immediately available for retrieval by and transfer to other authorized practitioners for their review and collaboration.

VivaNet is an Internet-based, DICOM-compliant application that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images. DICOM (Digital Imaging and Communications in Medicine) is an internationally accepted, and widely used standard for the secure storage, retrieval and transfer of medical images. HIPAA-compliance, privacy, and data integrity are assured by using proven DICOM compliant software modules that incorporate advanced encryption techniques.

For more information or to see a live demo of the VivaScope or VivaNet technology, visit Lucid at the World Congress of Dermatology show in booth #35, in Buenos Aires, Argentina. Or, visit Lucid online at http://www.lucid-tech.com/, by email: info@lucid-tech.com, or by phone: +1-585-239-9800.

About Lucid, Inc.
Lucid, Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to deploying its innovative cellular imaging technology and using the VivaNet Internet based medical information system to securely deliver accurate, real-time VivaScope cellular resolution images to medical professionals. When coupled with its digital VivaNet system, the company’s ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit http://www.lucid-tech.com/ or call +1-585-239-9800.
# # #

Public Relations contact: Tiziani Whitmyre Inc., http://www.tizinc.com/

post to del.icio.us






Technorati tags: , , , , , , , , , , , , , , ,

Labels: , , , , , , , , , , ,

Wednesday, September 05, 2007

Lucid Appoints Dr. Clifford Perlis as U.S. Medical Director

ROCHESTER, NEW YORK, USA – September 5, 2007Lucid, Inc., a leading U.S. cellular imaging and technology company, today announced the appointment of Clifford Perlis, M.D., M.Be., as the new U.S. Medical Director. He is currently the Director of Mohs Surgery in the Department of Medical Oncology at Fox Chase Cancer Center in Philadelphia.

In the newly created position at Lucid, Dr. Perlis will play a key role in the direction of Lucid’s clinical and medical research programs, support medical training and marketing initiatives, and aid in the submission of IRB protocols to third party organizations.

Dr. Perlis received his M.D. degree from the University of Pennsylvania School of Medicine in Philadelphia, and also holds a Masters in Bioethics from the University of Pennsylvania.

“Lucid is an innovative and dynamic company with a broad technology portfolio in the medical imaging and information fields. The company plans to initially apply these innovative imaging technologies in the field of dermatology, allowing my peers to attain a level of diagnostic capability similar to that radiologists routinely achieve using MRI and CT scans of the body. Ultimately, Lucid’s confocal imaging technology will be applied in numerous other medical technologies,” said Dr. Perlis.

Lucid is the creator of the non-invasive VivaScope® confocal microscope that provides cellular resolution images of skin, and of the VivaNet™, an Internet-based, DICOM-compliant medical information system that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images.

“As Lucid moves toward the launch of its clinical applications for VivaScopes and the VivaNet, it is important to have a voice on our management team that can express the needs of physicians and patients to our Board of Directors and the company’s outside stakeholders. Dr. Clifford Perlis, a practicing dermatologic surgeon with degrees in medicine and bioethics is very well suited to this role. I look forward to working with Dr. Perlis as we move Lucid’s unique technologies into routine medical practice around the world.” said Jay Eastman, Chairman and CEO of Lucid, Inc.

About Lucid Inc.
Lucid Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to deploying its innovative cellular imaging technology and using the VivaNet Internet based medical information system to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. When coupled with its digital VivaNet(TM) system, the company’s ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit http://www.lucid-tech.com or call +1-585-239-9800.

# # #

Public Relations contact: Tiziani Whitmyre Inc.

post to del.icio.us



Technorati tags: , , , , , , , , , , , , , , ,

Labels: , , , , , , , , , , ,

Tuesday, August 07, 2007

New Studies Show Effectiveness of Reflective Confocal Microscopy

ROCHESTER, NEW YORK, USA – August 7, 2007 – Three important new studies published in leading peer reviewed journals of dermatology have further demonstrated the effectiveness of reflective confocal microscopy (RCM) as a diagnostic tool in dermatology, said Jay Eastman, chairman and CEO of Lucid, Inc (http://www.lucid-tech.com/).

“These findings are quite encouraging, especially as we continue to launch pilots throughout Europe and the United States that are expected to demonstrate the success of RCM in routine private practice use,” he added.

Lucid, an innovative cellular imaging and technology company, is creator of the non-invasive VivaScope® reflective confocal microscope that provides cellular resolution images of skin and the VivaNet™, an Internet-based, DICOM-compliant application that enables the transfer of VivaScope® digital images between practitioners and pathologists for rapid review of confocal images.

The three articles Eastman cited are:

  • Diving into the blue: In vivo microscopic characterization of the dermoscopic blue hue,” in the July 2007 issue of the Journal of the American Academy of Dermatology. The article details a study that sought to identify “the in vivo confocal microscopy correlates of the blue hue for improving diagnostic accuracy for melanoma,” and determined that “confocal microscopy enabled the in vivo identification of characteristic cytological substrates correlated with the blue features in dermoscopy.” The article, by authors: G. Pellacani, S. Bassoli, C. Longo, AM. Cesinaro, S. Seidenari, can be found in Volume 57, pp 96-104, or accessed online at http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=17485141.
  • In vivo reflectance confocal microscopy of mycosis fungoides: A preliminary study,” in the April 2007 issue of the Journal of American Academy of Dermatology. The study objective “was to evaluate lesions suggestive of MF (mycosis fungoides) using in vivo reflectance confocal microscopy (RCM) and to correlate confocal features with histopathologic findings.” Study results found that “…features correlating well to histophathology are observed on RCM of MF lesions.” The article, by authors: AL. Agero, M. Gill, M. Ardigo, P. Myskowski, AC. Halpern, S. Gonzalez, was published online April 13, 2007 and can be accessed at: http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17433849&dopt=Citation.
  • "Preliminary evaluation of in vivo reflectance confocal microscopy features of discoid lupus erythematosus,” in the June 2007 issue of the British Journal of Dermatology. The study intended to “define RCM features of DLE and to evaluate its feasibility in biopsy site selection” and concluded that “RCM… appears to be promising for biopsy site selection.” The article, by authors: M. Ardigo, I. Maliszewski, C. Cota, A. Scope, G. Sacerdoti, S. Gonzalez, E. Berardesca, can be accessed in Volume 156, pp 1196-1203, or online at http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2133.2007.07808.x.

For more information about Lucid and their reflective confocal technologies, visit http://www.lucid-tech.com/ or call 1-585-239-9800.

About Lucid Inc.
Lucid Inc., based in Rochester, New York, USA, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. When coupled with its digital VivaNetTM system, the company’s ability to image in-vivo (living) tissue will aid medical practitioners and pathologists in skin cancer screening with clarity, speed and patient comfort. For more information about Lucid Inc., visit http://www.lucid-tech.com/.


# # #


Public Relations contact: Tiziani Whitmyre Inc.

post to del.icio.us





Technorati tags: , , , , , , , , , , , , , , ,

Labels: , , , , , , , , ,

Thursday, August 02, 2007

Lucid to Showcase VivaNetTM Telemedicine Server for Dermatology Applications at AAD Summer Academy Meeting

ROCHESTER, NEW YORK – August 1, 2007 - Lucid, Inc. (http://www.lucid-tech.com/) will showcase its VivaNetTM telemedicine server for dermatology applications at the American Academy of Dermatology’s (AAD) Summer Academy Meeting, August 1-5, 2007.

The VivaNetTM server is intended to link dermatology practitioners using Lucid’s non-invasive VivaScope® confocal imagers with other dermatologists or pathologists via the Internet.

Lucid’s non-invasive VivaScope® confocal microscopes provide cellular resolution images of skin that may be used by a dermatologist to assist in forming a clinical judgment for a variety of skin conditions. The VivaNetTM is an Internet-based, DICOM compliant application that is intended to provide fast, accurate, and secure storage, retrieval and transfer of VivaScope® digital cellular resolution images across the Internet to facilitate professional collaboration and consultation.

During a typical VivaScope® session, both dermatoscopic quality, full color macroscopic pictures and microscopic, cellular resolution images of the patient’s skin are imaged. Once all of the images from a single session are completed, the images and patient related data are transferred for storage to the secure VivaNetTM server and are immediately available for retrieval by and transfer to other authorized practitioners for their review and collaboration.

For more information or to see a live demo of the new VivaNet™ or VivaScope® technology, visit Lucid at the AAD Summer Academy Meeting, in booth #414 in the Hilton New York, August 1-5, 2007.

Or, visit Lucid online at http://www.lucid-tech.com/ or by phone 585-239-9800.

Lucid Inc., based in Rochester, New York, is a medical device and information company dedicated to creating innovative cellular imaging technology and using the Internet to securely deliver accurate, real-time VivaScope® cellular resolution images to medical professionals. The Company’s digital VivaNetTM server, coupled with its ability to image in-vivo (living) tissue is envisioned to ultimately aid medical practitioners and pathologists in screening for skin cancer and other dermatologic conditions with clarity, speed and patient comfort. For more information, visit http://www.lucid-tech.com/.

# # #

Public Relations contact: Tiziani Whitmyre Inc.

post to del.icio.us



Technorati tags: , , , , , , , , , , , , , , ,

Labels: , , , , , , , , , , ,

Friday, July 27, 2007

Dermatologists and Pathologists Assemble for In-Depth Training on Confocal Diagnostic Imaging Interpretation

ROCHESTER, NY – July 27, 2007 – More than two dozen dermatologists and pathologists assembled in New York City for the first in a series of in-depth courses to train future diagnostic readers on the interpretation of in-vivo confocal images of pigmented lesions.

Led by one of the world’s leading in-vivo confocal imaging medical researchers, Dr. Giovanni Pellacani fr